Balaji Amines Ltd on July 10, 2007 has announced that it has revamped its Methyl Amines plant by adding the balancing equipments. This re-vamping has resulted in increase of its production capacity by 30% which will increase the Top line by about 15% and contribute to the Bottom line as well.
The Company has also announced that its Morpholine plant, which started full stream from this financial year, has stabilized and the product is being accepted by its major customers. Morpholine is being manufactured by the Company for the first time in India through new Process developed in its in House R &D.
The stock was trading at Rs.120, up by Rs.1.65 or 1.39%. The stock hit an intraday high of Rs.120 and low of Rs.117. The total traded quantity was 2176 compared to 2 week average of 2527.